Skip to main content
DBVT logo

DBVT · DBV Technologies S.A. · Investor Relations

Track DBVT — free
$9.61 -0.07 (-0.72%) Play latest call Q3 2026 earnings call transcript
Market Cap
$608.30M
Shares
62.84M
Volume · Nov 19 173.38K Avg daily vol (3M) 349.1K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Past events

Date Event Type
2026-11-16 2026 LifeSci Growth & Innovation Summit Conference
2026-11-12 ACAAI 2026 Annual Scientific Meeting Event
2026-11-09 Guggenheim Securities 3rd Annual Healthcare Innovation Conference Conference
2026-11-09 The 3rd Annual Guggenheim Healthcare Innovation Conference Conference
2026-10-28 Q3 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-10-15 CSACI (Canadian Society of Allergy and Clinical Immunology) 81st Annual Scientific Meeting Event
2026-10-02 SHC Congress 2026 Event
2026-09-15 H.C. Wainwright 28th Annual Global Investment Event
2026-09-09 2026 Cantor Global Healthcare Conference Conference
2026-07-29 First Half Quarterly Update Event
2026-07-23 APA-AAI Conference 2026 Conference
2026-07-16 Earnings conference call (announced in 8-K) Earnings call
2026-06-29 DBV Update Conference Call Conference
2026-06-03 2026 Annual General Meeting Shareholder meeting
2026-05-28 Eastern Allergy Conference Conference
2026-05-19 H.C. Wainwright BioConnect Conference Conference
2026-04-30 Q1 Quarterly Update Event
2026-03-10 The Citizens Life Sciences Conference Conference
2026-02-27 American Academy of Allergy, Asthma & Immunology Annual Meeting 2026 Shareholder meeting
2026-02-12 Guggenheim Securities Emerging Outlook: Biotech Summit Event
2025-12-16 VITESSE Topline Results Conference Call Earnings call
2025-11-11 DBV Technologies to Participate in the Guggenheim Second Annual Healthcare Innovation Conference Conference
2025-09-09 DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Conference

Source: https://dbv-technologies.com/investor-overview/events/

Key facts CIK 1613780 CUSIP 23306J309 13F (30d) 66 filings 63 filers Visit website Investor relations